He is an Associate Professor of Urology at the Universitat Autónoma de Barcelona (Spain) and Chief of the Urological Oncology Department at the famous Fundació Puigvert in Barcelona.
Dr. Palou is Chairman of the European School of Urology.
He is, among many others, member of the Spanish Urological Association, European Association of Urology (EAU), American Urological Association and Société International d’Urologie.
Dr. Palou is an expert in laparoscopy and robotic surgery belonging to a cooperative group in robotic radical cystectomy. He has collaborated with the International Consultation on Bladder Cancer and Penile Cancer, sponsored by the WHO and SIU. Most importantly, he has been involved in writing the EAU Guidelines for non-muscle invasive bladder cancer and upper urinary tract tumours. Dr. Palou has published many chapters in medical and urology books and more than 150 publications in peer-reviewed journals. His recent publications focus mainly on bladder cancer studying the different aspects such as prognostic factors, BCG, T1G2 tumors, T1G3 tumors, guidelines, risk stratification or robotic surgery. A new protein marker of aggressiveness and prognosis of progression in patients with T1G3 tumours of the bladder has been developed with the CNIO (National Center for Oncologic Investigations) with encouraging results. He is also a referee of several national and international journals.
He has given countless lectures in national and international meetings and as a visiting professor in University Hospitals all over the world. His group has received several awards for publications, videos, oral and poster presentations at different meetings. The most known is the Hans Marberger prize in 2004.